Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleRAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer.AuthorsHelden, Erik J.; Angus, Lindsay; Menke‐van der Houven van Oordt, C. Willemien; Heideman, Daniëlle A. M.; Boon, Eline; Es, Suzanne C.; Radema, Sandra A.; Herpen, Carla M. L.; Groot, Derk Jan A.; Vries, Elisabeth G. E.; Jansen, Maurice P. H. M.; Sleijfer, Stefan; Verheul, Henk M. W.PublicationMolecular Oncology, 2019, Vol 13, Issue 11, p2361ISSN1574-7891Publication typeArticleDOI10.1002/1878-0261.12550